|
Biology and function of SALL4-induced hematopoietic stem cells from cord blood
|
1K01CA163999-01
|
$130,694
|
Aguila, Jerell
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
The CCNY/MSKCC Partnership for Research, Training and Outreach
|
3U54CA137788-04S1
|
$168,098
|
Ahles, Tim
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The CCNY/MSKCC Partnership for Research, Training and Outreach
|
5U54CA137788-04
|
$1,332,003
|
Ahles, Tim
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Antigen Specific T Cell tolerance by Anti CD3 Antibodies
|
5R01CA132197-09
|
$365,441
|
ANASETTI, CLAUDIO
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
5P01CA078378-12
|
$1,984,614
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-19
|
$278,781
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$650,805
|
Anderson, Stephen
|
CCR (NCI)
|
|
THE THERAPY OF AML
|
5P01CA055164-19
|
$2,401,083
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Mechanisms of GVHD
|
5P01CA142106-08
|
$1,867,308
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$273,950
|
Aplan, Peter
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
5P01CA018029-36
|
$5,431,018
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-27
|
$615,630
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
ZIA SC 010282
|
$121,487
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$425,206
|
Arthur, Diane
|
CCR (NCI)
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIA BC 010997
|
$85,103
|
Avital, Itzhak
|
CCR (NCI)
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$170,206
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$255,308
|
Avital, Itzhak
|
CCR (NCI)
|
|
Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch
|
ZIA BC 011005
|
$170,206
|
Avital, Itzhak
|
CCR (NCI)
|
|
The role of CD200 in T cell therapy of cancer
|
5R01CA138427-03
|
$241,530
|
BAI, XUE-FENG
|
OHIO STATE UNIVERSITY
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-32S1
|
$665,444
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-32
|
$8,893,886
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-27
|
$2,878,195
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-17
|
$3,653,305
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-12
|
$2,117,925
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Surgical Oncology Research Training
|
5T32CA106493-07
|
$114,198
|
BEHRNS, KEVIN
|
UNIVERSITY OF FLORIDA
|
|
Targeted Radiotherapy with 90Y-BC8 Monclonal Antibody, Fludarabine and TBI Follow
|
1R21CA155911-01
|
$352,615
|
BENSINGER, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-13
|
$377,387
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-33
|
$177,227
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
ZIA BC 010698
|
$55,940
|
Bishop, Michael
|
CCR (NCI)
|
|
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$55,940
|
Bishop, Michael
|
CCR (NCI)
|
|
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
|
ZIA SC 010365
|
$74,587
|
Bishop, Michael
|
CCR (NCI)
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-02
|
$188,304
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
1K23CA154532-01
|
$169,590
|
Bleakley, Marie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Enhancing Treg Immune Reconstitution After Stem Cell Transplant
|
1R21CA149967-01A1
|
$325,834
|
BOLLARD, CATHERINE
|
BAYLOR COLLEGE OF MEDICINE
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-05
|
$302,252
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Lineage-restricted Minor Histocompatibility Antigens as GVL Targets
|
5R01CA118880-05
|
$228,126
|
BRICKNER, ANTHONY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The Therapy of CML
|
5P01CA049639-21
|
$3,438,273
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-18
|
$1,781,177
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
1K07CA151775-01A1
|
$151,059
|
Chow, Eric
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genetic Therapy for Fanconi Anemia
|
1R01CA155294-01
|
$319,550
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Mechanisms of Symptoms of Multiple Myeloma and Its Therapy
|
5P01CA124787-04
|
$1,979,082
|
CLEELAND, CHARLES
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Enhancing the efficacy of CD19-specific cord blood-derived T Cells
|
5R01CA120956-05
|
$283,822
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-05
|
$283,822
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia
|
5R01CA141303-02
|
$318,015
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S1
|
$116,988
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S2
|
$704,000
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S3
|
$211,800
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S4
|
$75,000
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|